These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 25755063)

  • 1. Safety and efficacy of intracoronary hypoxia-preconditioned bone marrow mononuclear cell administration for acute myocardial infarction patients: The CHINA-AMI randomized controlled trial.
    Hu X; Huang X; Yang Q; Wang L; Sun J; Zhan H; Lin J; Pu Z; Jiang J; Sun Y; Xiang M; Liu X; Xie X; Yu X; Chen Z; Tse HF; Zhang J; Wang J
    Int J Cardiol; 2015 Apr; 184():446-451. PubMed ID: 25755063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial.
    Traverse JH; Henry TD; Ellis SG; Pepine CJ; Willerson JT; Zhao DX; Forder JR; Byrne BJ; Hatzopoulos AK; Penn MS; Perin EC; Baran KW; Chambers J; Lambert C; Raveendran G; Simon DI; Vaughan DE; Simpson LM; Gee AP; Taylor DA; Cogle CR; Thomas JD; Silva GV; Jorgenson BC; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Smith DX; Baraniuk S; Piller LB; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2011 Nov; 306(19):2110-9. PubMed ID: 22084195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial.
    Roncalli J; Mouquet F; Piot C; Trochu JN; Le Corvoisier P; Neuder Y; Le Tourneau T; Agostini D; Gaxotte V; Sportouch C; Galinier M; Crochet D; Teiger E; Richard MJ; Polge AS; Beregi JP; Manrique A; Carrie D; Susen S; Klein B; Parini A; Lamirault G; Croisille P; Rouard H; Bourin P; Nguyen JM; Delasalle B; Vanzetto G; Van Belle E; Lemarchand P
    Eur Heart J; 2011 Jul; 32(14):1748-57. PubMed ID: 21127322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is the measurement of left ventricular ejection fraction the proper end point for cell therapy trials? An analysis of the effect of bone marrow mononuclear stem cell administration on left ventricular ejection fraction after ST-segment elevation myocardial infarction when evaluated by cardiac magnetic resonance imaging.
    Traverse JH; Henry TD; Moye' LA
    Am Heart J; 2011 Oct; 162(4):671-7. PubMed ID: 21982659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.
    Meyer GP; Wollert KC; Lotz J; Steffens J; Lippolt P; Fichtner S; Hecker H; Schaefer A; Arseniev L; Hertenstein B; Ganser A; Drexler H
    Circulation; 2006 Mar; 113(10):1287-94. PubMed ID: 16520413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial.
    Assmus B; Walter DH; Seeger FH; Leistner DM; Steiner J; Ziegler I; Lutz A; Khaled W; Klotsche J; Tonn T; Dimmeler S; Zeiher AM
    JAMA; 2013 Apr; 309(15):1622-31. PubMed ID: 23592107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial.
    Traverse JH; Henry TD; Pepine CJ; Willerson JT; Zhao DX; Ellis SG; Forder JR; Anderson RD; Hatzopoulos AK; Penn MS; Perin EC; Chambers J; Baran KW; Raveendran G; Lambert C; Lerman A; Simon DI; Vaughan DE; Lai D; Gee AP; Taylor DA; Cogle CR; Thomas JD; Olson RE; Bowman S; Francescon J; Geither C; Handberg E; Kappenman C; Westbrook L; Piller LB; Simpson LM; Baraniuk S; Loghin C; Aguilar D; Richman S; Zierold C; Spoon DB; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Dec; 308(22):2380-9. PubMed ID: 23129008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Mononuclear Cells Transfer for Patients after ST-Elevated Myocardial Infarction: A Meta-Analysis of Randomized Control Trials.
    Zhang J; Lin L; Zong W
    Yonsei Med J; 2018 Jul; 59(5):611-623. PubMed ID: 29869459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function.
    Yao K; Huang R; Qian J; Cui J; Ge L; Li Y; Zhang F; Shi H; Huang D; Zhang S; Sun A; Zou Y; Ge J
    Heart; 2008 Sep; 94(9):1147-53. PubMed ID: 18381377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction.
    Lunde K; Solheim S; Aakhus S; Arnesen H; Abdelnoor M; Egeland T; Endresen K; Ilebekk A; Mangschau A; Fjeld JG; Smith HJ; Taraldsrud E; Grøgaard HK; Bjørnerheim R; Brekke M; Müller C; Hopp E; Ragnarsson A; Brinchmann JE; Forfang K
    N Engl J Med; 2006 Sep; 355(12):1199-209. PubMed ID: 16990383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Tijssen JG; van der Giessen WJ; Tio RA; Waltenberger J; ten Berg JM; Doevendans PA; Aengevaeren WR; Zwaginga JJ; Biemond BJ; van Rossum AC; Piek JJ; Zijlstra F;
    Eur Heart J; 2011 Jul; 32(14):1736-47. PubMed ID: 21148540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale for the Myocardial Stem Cell Administration After Acute Myocardial Infarction (MYSTAR) Study: a multicenter, prospective, randomized, single-blind trial comparing early and late intracoronary or combined (percutaneous intramyocardial and intracoronary) administration of nonselected autologous bone marrow cells to patients after acute myocardial infarction.
    Nyolczas N; Gyöngyösi M; Beran G; Dettke M; Graf S; Sochor H; Christ G; Edes I; Balogh L; Krause KT; Jaquet K; Kuck KH; Benedek I; Hintea T; Kiss R; Préda I; Kotevski V; Pejkov H; Dudek D; Heba G; Sylven C; Charwat S; Jacob R; Maurer G; Lang I; Glogar D
    Am Heart J; 2007 Feb; 153(2):212.e1-7. PubMed ID: 17239678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial.
    Tendera M; Wojakowski W; Ruzyłło W; Chojnowska L; Kepka C; Tracz W; Musiałek P; Piwowarska W; Nessler J; Buszman P; Grajek S; Breborowicz P; Majka M; Ratajczak MZ;
    Eur Heart J; 2009 Jun; 30(11):1313-21. PubMed ID: 19208649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial†.
    Choudry F; Hamshere S; Saunders N; Veerapen J; Bavnbek K; Knight C; Pellerin D; Locca D; Westwood M; Rakhit R; Crake T; Kastrup J; Parmar M; Agrawal S; Jones D; Martin J; Mathur A
    Eur Heart J; 2016 Jan; 37(3):256-63. PubMed ID: 26405233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial Infarction study (REPAIR-AMI) cardiac magnetic resonance imaging substudy.
    Dill T; Schächinger V; Rolf A; Möllmann S; Thiele H; Tillmanns H; Assmus B; Dimmeler S; Zeiher AM; Hamm C
    Am Heart J; 2009 Mar; 157(3):541-7. PubMed ID: 19249426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival.
    Assmus B; Leistner DM; Schächinger V; Erbs S; Elsässer A; Haberbosch W; Hambrecht R; Sedding D; Yu J; Corti R; Mathey DG; Barth C; Mayer-Wehrstein C; Burck I; Sueselbeck T; Dill T; Hamm CW; Tonn T; Dimmeler S; Zeiher AM;
    Eur Heart J; 2014 May; 35(19):1275-83. PubMed ID: 24569031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
    Perin EC; Willerson JT; Pepine CJ; Henry TD; Ellis SG; Zhao DX; Silva GV; Lai D; Thomas JD; Kronenberg MW; Martin AD; Anderson RD; Traverse JH; Penn MS; Anwaruddin S; Hatzopoulos AK; Gee AP; Taylor DA; Cogle CR; Smith D; Westbrook L; Chen J; Handberg E; Olson RE; Geither C; Bowman S; Francescon J; Baraniuk S; Piller LB; Simpson LM; Loghin C; Aguilar D; Richman S; Zierold C; Bettencourt J; Sayre SL; Vojvodic RW; Skarlatos SI; Gordon DJ; Ebert RF; Kwak M; Moyé LA; Simari RD;
    JAMA; 2012 Apr; 307(16):1717-26. PubMed ID: 22447880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial.
    Wollert KC; Meyer GP; Müller-Ehmsen J; Tschöpe C; Bonarjee V; Larsen AI; May AE; Empen K; Chorianopoulos E; Tebbe U; Waltenberger J; Mahrholdt H; Ritter B; Pirr J; Fischer D; Korf-Klingebiel M; Arseniev L; Heuft HG; Brinchmann JE; Messinger D; Hertenstein B; Ganser A; Katus HA; Felix SB; Gawaz MP; Dickstein K; Schultheiss HP; Ladage D; Greulich S; Bauersachs J
    Eur Heart J; 2017 Oct; 38(39):2936-2943. PubMed ID: 28431003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of intracoronary bone marrow cell therapy on left ventricular function in the setting of ST-segment elevation myocardial infarction: a collaborative meta-analysis.
    Delewi R; Hirsch A; Tijssen JG; Schächinger V; Wojakowski W; Roncalli J; Aakhus S; Erbs S; Assmus B; Tendera M; Goekmen Turan R; Corti R; Henry T; Lemarchand P; Lunde K; Cao F; Huikuri HV; Sürder D; Simari RD; Janssens S; Wollert KC; Plewka M; Grajek S; Traverse JH; Zijlstra F; Piek JJ
    Eur Heart J; 2014 Apr; 35(15):989-98. PubMed ID: 24026778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction.
    Huikuri HV; Kervinen K; Niemelä M; Ylitalo K; Säily M; Koistinen P; Savolainen ER; Ukkonen H; Pietilä M; Airaksinen JK; Knuuti J; Mäkikallio TH;
    Eur Heart J; 2008 Nov; 29(22):2723-32. PubMed ID: 18845667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.